MK-2748

DB15371InvestigationalSmall molecule

MK-2748 is under investigation in clinical trial NCT01593735 (A Multiple Dose Study to Evaluate the Safety and Efficacy of MK-2748 in Hepatitis C-Infected Participants (MK-2748-002 AM1)).

Formula / weight: C₄₂H₅₆N₆O₁₀S · 837.0 g/mol (avg)
Code names: MK-2748

Resolves to

Compound

UNII7YM030A71CCAS1193902-95-2

Structure

InChIKeyHMYVZDWJFQOHCD-XEZGQWAWSA-NSMILES

COC1=CC2=C(C=C1)C(=O)N1CCCCC[C@@H]3CCC[C@H]3OC(=O)N[C@@H](C3CCCC3)C(=O)N3C[C@@H](C[C@H]3C(=O)N[C@@]3(C[C@H]3C=C)C(=O)NS(=O)(=O)C3(C)CC3)OC1=N2

What you can answer from here — as of April 02, 2025

1Clinical trialPhase, status and sponsor resolved per trial

Which companies are running trials of MK-2748, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account